Stapedial Reflex: A Possible Novel Biomarker of Early Bulbar Involvement in Amyotrophic Lateral Sclerosis Patients.

Acoustic reflex Amyotrophic lateral sclerosis Biomarker Bulbar impairment Stapedial reflex

Journal

Audiology & neuro-otology
ISSN: 1421-9700
Titre abrégé: Audiol Neurootol
Pays: Switzerland
ID NLM: 9606930

Informations de publication

Date de publication:
2021
Historique:
received: 19 05 2020
accepted: 30 11 2020
pubmed: 14 4 2021
medline: 26 10 2021
entrez: 13 4 2021
Statut: ppublish

Résumé

Amyotrophic lateral sclerosis (ALS) is a neuromuscular progressive disorder, characterized by limb and bulbar muscle wasting and weakness. 30% of patients present a bulbar onset, while 70% a spinal outbreak, although most of them develop bulbar impairment later on. Due to the lack of an early biomarker of bulbar involvement, we chose to evaluate the role of stapedial reflex (SR) in order to predict preclinical bulbar impairment in ALS. We enrolled 36 ALS patients. We assessed revised-ALS functional-rating-scale and SR for a total of 4 visits. We established the presence of SR, acoustic reflex latency test (ARLT), and SRs Decay. Patients who had not develop bulbar signs at fourth visit continued follow-up up to 15 months. Data were analyzed by using Mann-Whitney U test, Friedman test, and Cox regression analysis. We observed that SRs Decay at 500 and 1,000 Hz is the first parameter of SR to get altered in all ALS patients before the development of bulbar impairment. Twenty-eight patients developed bulbar impairment during the study. We highlighted a correlation between the progression rate of disease and both time of SRs Decay alteration and time of bulbar impairment from disease onset. Four patients who did not develop bulbar impairment had a progression rate lower than the other ones (p < 0.05). This study shows that SR Decay test could be a sensitive measure for detecting pre-symptomatic bulbar involvement in ALS and could represent a simple, noninvasive, and useful biomarker of disease progression.

Sections du résumé

BACKGROUND AND AIM
Amyotrophic lateral sclerosis (ALS) is a neuromuscular progressive disorder, characterized by limb and bulbar muscle wasting and weakness. 30% of patients present a bulbar onset, while 70% a spinal outbreak, although most of them develop bulbar impairment later on. Due to the lack of an early biomarker of bulbar involvement, we chose to evaluate the role of stapedial reflex (SR) in order to predict preclinical bulbar impairment in ALS.
MATERIALS AND METHODS
We enrolled 36 ALS patients. We assessed revised-ALS functional-rating-scale and SR for a total of 4 visits. We established the presence of SR, acoustic reflex latency test (ARLT), and SRs Decay. Patients who had not develop bulbar signs at fourth visit continued follow-up up to 15 months. Data were analyzed by using Mann-Whitney U test, Friedman test, and Cox regression analysis.
RESULTS
We observed that SRs Decay at 500 and 1,000 Hz is the first parameter of SR to get altered in all ALS patients before the development of bulbar impairment. Twenty-eight patients developed bulbar impairment during the study. We highlighted a correlation between the progression rate of disease and both time of SRs Decay alteration and time of bulbar impairment from disease onset. Four patients who did not develop bulbar impairment had a progression rate lower than the other ones (p < 0.05).
DISCUSSION AND CONCLUSIONS
This study shows that SR Decay test could be a sensitive measure for detecting pre-symptomatic bulbar involvement in ALS and could represent a simple, noninvasive, and useful biomarker of disease progression.

Identifiants

pubmed: 33849007
pii: 000513482
doi: 10.1159/000513482
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

353-360

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Alessandro Bombaci (A)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Chiara Lazzaro (C)

ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.

Carola Amalia Bertoli (CA)

ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.

Michelangelo Lacilla (M)

ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.

Drita Ndrev (D)

ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.

Adriano Chiò (A)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Andrea Albera (A)

ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.

Andrea Calvo (A)

"Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Andrea Canale (A)

ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH